Cargando…
Current understanding of reovirus oncolysis mechanisms
Mammalian orthoreovirus (reovirus) is under development as a cancer virotherapy. Clinical trials demonstrate that reovirus-based therapies are safe and tolerated in patients with a wide variety of cancers. Although reovirus monotherapy has proven largely ineffective, reovirus sensitizes cancer cells...
Autores principales: | Phillips, Matthew B, Stuart, Johnasha D, Rodríguez Stewart, Roxana M, Berry, Jameson TL, Mainou, Bernardo A, Boehme, Karl W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005300/ https://www.ncbi.nlm.nih.gov/pubmed/29942799 http://dx.doi.org/10.2147/OV.S143808 |
Ejemplares similares
-
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020) -
Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus
por: Simon, Emily J., et al.
Publicado: (2017) -
Attenuated reovirus displays oncolysis with reduced host toxicity
por: Kim, M, et al.
Publicado: (2011) -
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants
por: Mohamed, Adil, et al.
Publicado: (2015) -
Proteolytic Disassembly Is a Critical Determinant for Reovirus Oncolysis
por: Alain, Tommy, et al.
Publicado: (2007)